Support
Benedict
The Lymphotoxin-Interferon Antiviral Immunity Axis

Over the last 15 years our lab has been studying the link between lymphotoxins (LT) and the regulation of type

READ MORE
Benedict
CMV Targets the Immune Checkpoint Inhibitor BTLA

Virulent isolates of CMV encode the ul144 orf, and we identified UL144 as an orthologue of the herpesvirus entry mediator

READ MORE
Benedict
T Cell Immunity and CMV

HCMV-specific CD8 T cells protect bone marrow transplant patients when used in cellular immunotherapy, and their long-term maintenance is enhanced

READ MORE
Benedict
CMV Interfaces with The Trail Cytokine System

We have recently discovered a novel connection between the TNF-related apoptosis inducing ligand (TRAIL) cytokine system and CMV. TRAIL is

READ MORE
Benedict Lab
Christopher Benedict, Ph.D.
Associate Professor
Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research

Christopher Benedict, Ph.D., studies the strategies that viruses use to escape detection by our immune system.

Read More
Mar 29, 2017 Immune Matters
Q&A with Dr. Benedict

As a scientist Chris Benedict, Ph.D., came of age during the heyday of gene therapy. But when the first clinical

Read More
Jan 4, 2016
Chris Benedict

Institute Leadership Assistant Professor of Computational Biology, Additional title, another title.

Read More